Wuzi Yanzong Pill—Based on Network Pharmacology and In Vivo Evidence—Protects Against Spermatogenesis Disorder via the Regulation of the Apoptosis Pathway

Wang-qiang Chen,Cai-fei Ding,Jia Yu,Chen-ye Wang,Ling-yi Wan,Hui-min Hu,Jian-xiong Ma
DOI: https://doi.org/10.3389/fphar.2020.592827
IF: 5.6
2020-12-18
Frontiers in Pharmacology
Abstract:The crisis of male infertility is an issue of human reproductive health worldwide. The Wuzi Yanzong pill (WZYZP) is a traditional Chinese medicine prescription that shows efficacy in kidney reinforcement and essence benefit to ameliorate male reproductive dysfunctions. However, the pharmacological mechanisms of the WZYZP on male infertility have not been investigated and clarified clearly. This study was designed to investigate the effects of the WZYZP on spermatogenesis disorder and explore its underlying pharmacological mechanisms. First, based on a network pharmacology study, 39 bioactive compounds and 40 targets of the WZYZP associated with spermatogenesis disorder were obtained, forming a tight compound-target network. Molecular docking tests showed tight docking of these compounds with predicted targeted proteins. The protein–protein interaction (PPI) network identified TP53, TNF, AKT1, Bcl-XL, Bcl-2, and IκBA as hub targets. The Kyoto Encyclopedia of Genes and Genomes pathway network and pathway-target-compound network revealed that the apoptosis pathway was enriched by multiple signaling pathways and multiple targets, including the hub targets. Subsequently, the chemical characterization of WZYZP was analyzed using liquid chromatography to quadrupole/time-of-flight mass spectrometry, and 40 compounds in positive ion mode and 41 compounds in negative ion mode in the WZYZP were identified. Furthermore, based on the prediction of a network pharmacology study, a rat model of spermatogenesis disorder was established to evaluate the curative role and underlying mechanisms of the WZYZP. The results showed that WZYZP treatment improved rat sperm quality and attenuated serum hormone levels, reversed histopathological damage of the testis, reduced cell apoptosis in testis tissues, and ameliorated the expression of the predicted hub targets (TP53, TNF-α, AKT1, NFκB, and IκBA) and the apoptosis related proteins (Bcl-XL, Bcl-2, Bax, Caspase 3, and Caspase 9). These results indicated that the WZYZP has a protective effect on spermatogenesis disorder, suggesting that it could be an alternative choice for male infertility therapy.
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the protective effect of Wuzi Yanzong Pill (WZYZP) on spermatogenic disorder and its potential pharmacological mechanisms. Specifically, the study aims to verify the influence of WZYZP on spermatogenic disorder through network pharmacology analysis and in - vivo experiments, and to explore the mechanism by which it improves male reproductive dysfunction by regulating the apoptotic pathway. It is mentioned in the paper that male infertility is a global reproductive health problem, accounting for approximately 40% of infertility cases worldwide. Wuzi Yanzong Pill is a traditional Chinese medicine compound formula, which has the effect of tonifying the kidney and replenishing essence, and can be used to improve male reproductive dysfunction, such as impotence, asthenospermia, oligospermia, spermatorrhea and premature ejaculation, etc. However, the pharmacological mechanism of WZYZP in male infertility has not been fully elucidated. Therefore, this study screened the active compounds and their targets in WZYZP through the network pharmacology method, and constructed a drug - compound - target network. Furthermore, key targets were determined through molecular docking and protein - protein interaction network analysis. In addition, an animal model of spermatogenic disorder was established to evaluate the therapeutic effect of WZYZP and its regulatory effect on the apoptotic pathway. The research results show that WZYZP can improve sperm quality, reduce serum hormone levels, alleviate pathological damage to testicular tissue, reduce cell apoptosis, and improve the expression of predicted key targets (such as TP53, TNF - α, AKT1, NF - κB and IκBA) and apoptosis - related proteins (such as Bcl - XL, Bcl - 2, Bax, Caspase 3 and Caspase 9). These results indicate that WZYZP has a protective effect on spermatogenic disorder and may become an alternative option for the treatment of male infertility.